Vertex Pharmaceuticals Incorporated VRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

84/100

5/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Vertex Pharmaceuticals Incorporated (VRTX), incluyendo 1 compra y 48 ventas. El total de compras internas fue valorado en RSU Award y el total de ventas internas en $50.44M.

Internos destacados con actividad reciente incluyen Liu Joy, Bozic Carmen, Mckechnie Duncan. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — VRTX

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-04-01	Liu Joy	EVP and Chief Legal Officer	Venta Informativa	978	$449.17	$439.29K	21,833
2026-03-27	Bozic Carmen	EVP and CMO	Venta Informativa	2,329	$450.95	$1.05M	33,076
2026-03-13	Bozic Carmen	EVP and CMO	Venta Informativa	2,329	$481.79	$1.12M	35,405
2026-03-11	Mckechnie Duncan	EVP, Chief Commercial Officer	Venta Informativa	2,633	$498.42	$1.31M	12,489
2026-03-04	Mckechnie Duncan	EVP, Chief Commercial Officer	Venta Informativa	2,437	$475.30	$1.16M	15,122
2026-03-02	Liu Joy	EVP and Chief Legal Officer	Venta Informativa	892	$495.96	$442.4K	22,811
2026-03-01	Liu Joy	EVP and Chief Legal Officer	Desconocido	7,044	$155.57	$1.1M	-
2026-02-27	Kewalramani Reshma	CEO & President	Venta Informativa	1,725	$496.95	$857.24K	98,278
2026-02-27	Bozic Carmen	EVP and CMO	Venta Informativa	2,329	$480.31	$1.12M	37,734
2026-02-26	Ambrose Kristen	SVP & Chief Accounting Officer	Venta Informativa	357	$483.36	$172.56K	6,624
2026-02-25	Sachdev Amit	EVP Chief Patient & Ext Af Off	Venta Informativa	1,846	$486.35	$897.8K	55,570
2026-02-25	Biller Jonathan	EVP and Chief Legal Officer	Venta Informativa	945	$486.35	$459.6K	13,659
2026-02-25	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Venta Informativa	260	$486.35	$126.45K	46,763
2026-02-25	Ambrose Kristen	SVP & Chief Accounting Officer	Venta Informativa	223	$486.35	$108.46K	6,981
2026-02-25	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Venta Informativa	668	$486.35	$324.88K	18,432
2026-02-25	Mckechnie Duncan	EVP, Chief Commercial Officer	Venta Informativa	2,410	$489.00	$1.18M	17,559
2026-02-25	Bunnage Mark E.	EVP, Chief Scientific Officer	Venta Informativa	620	$486.35	$301.54K	7,284
2026-02-24	Wagner Charles F Jr	EVP, Co & Fo	Retención Fiscal de RSU	1,744	$485.11	$846.03K	47,042
2026-02-24	Leiden Jeffrey M	Executive Chairman	Retención Fiscal de RSU	3,547	$485.11	$1.72M	34,797
2026-02-24	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retención Fiscal de RSU	1,518	$485.11	$736.4K	57,416
2026-02-24	Kewalramani Reshma	CEO & President	Retención Fiscal de RSU	4,981	$485.11	$2.42M	138,278
2026-02-24	Biller Jonathan	EVP and Chief Legal Officer	Retención Fiscal de RSU	1,144	$485.11	$554.97K	14,604
2026-02-24	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Retención Fiscal de RSU	1,627	$485.11	$789.27K	47,023
2026-02-24	Bozic Carmen	EVP and CMO	Retención Fiscal de RSU	1,453	$485.11	$704.86K	40,063
2026-02-24	Ambrose Kristen	SVP & Chief Accounting Officer	Retención Fiscal de RSU	546	$485.11	$264.87K	7,204
2026-02-24	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Retención Fiscal de RSU	1,627	$485.11	$789.27K	19,100
2026-02-24	Mckechnie Duncan	EVP, Chief Commercial Officer	Retención Fiscal de RSU	873	$485.11	$423.5K	22,469
2026-02-24	Bunnage Mark E.	EVP, Chief Scientific Officer	Retención Fiscal de RSU	582	$485.11	$282.33K	7,904
2026-02-19	Sachdev Amit	EVP Chief Patient & Ext Af Off	Ejercicio de Opciones (Venta)	25,026	$187.53	$4.69M	-
2026-02-18	Leiden Jeffrey M	Executive Chairman	Retención Fiscal de RSU	2,964	$483.75	$1.43M	38,344
2026-02-18	Biller Jonathan	EVP and Chief Legal Officer	Venta Informativa	1,244	$473.68	$589.26K	15,748
2026-02-18	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Venta Informativa	368	$473.68	$174.31K	48,650
2026-02-18	Ambrose Kristen	SVP & Chief Accounting Officer	Venta Informativa	638	$473.68	$302.21K	7,750
2026-02-18	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Venta Informativa	817	$473.68	$387K	20,727
2026-02-18	Bunnage Mark E.	EVP, Chief Scientific Officer	Venta Informativa	1,182	$473.68	$559.89K	8,486
2026-02-17	Wagner Charles F Jr	EVP, Co & Fo	Retención Fiscal de RSU	2,294	$483.75	$1.11M	48,786
2026-02-17	Leiden Jeffrey M	Executive Chairman	Concesión de RSU	8,269	-	-	41,308
2026-02-17	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retención Fiscal de RSU	2,140	$483.75	$1.04M	69,042
2026-02-17	Kewalramani Reshma	CEO & President	Retención Fiscal de RSU	6,554	$483.75	$3.17M	143,259
2026-02-17	Biller Jonathan	EVP and Chief Legal Officer	Venta Informativa	2,476	$489.46	$1.21M	16,992
2026-02-17	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Venta Informativa	609	$489.46	$298.08K	49,018
2026-02-17	Bozic Carmen	EVP and CMO	Retención Fiscal de RSU	1,912	$483.75	$924.93K	41,516
2026-02-17	Ambrose Kristen	SVP & Chief Accounting Officer	Venta Informativa	1,557	$489.46	$762.09K	8,388
2026-02-17	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Venta Informativa	2,031	$489.46	$994.09K	21,544
2026-02-17	Mckechnie Duncan	EVP, Chief Commercial Officer	Retención Fiscal de RSU	1,148	$483.75	$555.35K	23,342
2026-02-17	Bunnage Mark E.	EVP, Chief Scientific Officer	Venta Informativa	2,437	$489.46	$1.19M	9,668
2026-02-13	Wagner Charles F Jr	EVP, Co & Fo	Retención Fiscal de RSU	4,565	$487.76	$2.23M	43,715
2026-02-13	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retención Fiscal de RSU	3,548	$487.76	$1.73M	65,393
2026-02-13	Bhatia Sangeeta N.	Director	Venta Informativa	266	$500.00	$133K	4,299
2026-02-13	Kewalramani Reshma	CEO & President	Retención Fiscal de RSU	13,041	$487.76	$6.36M	133,487

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento